243 related articles for article (PubMed ID: 32092817)
41. MiR-105-3p acts as an oncogene to promote the proliferation and metastasis of breast cancer cells by targeting GOLIM4.
Lin B; Liu C; Shi E; Jin Q; Zhao W; Wang J; Ji R
BMC Cancer; 2021 Mar; 21(1):275. PubMed ID: 33722196
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-3613-3p functions as a tumor suppressor and represents a novel therapeutic target in breast cancer.
Chen C; Pan Y; Bai L; Chen H; Duan Z; Si Q; Zhu R; Chuang TH; Luo Y
Breast Cancer Res; 2021 Jan; 23(1):12. PubMed ID: 33494814
[TBL] [Abstract][Full Text] [Related]
43. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.
Chen J; Zhao D; Meng Q
Biomed Pharmacother; 2019 Aug; 116():108966. PubMed ID: 31102936
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of miR-222-3p Promotes the Proliferation and Inhibits the Apoptosis of Diffuse Large B-Cell Lymphoma Cells via Suppressing PPP2R2A.
Sun S; Wang H; Ji M
Technol Cancer Res Treat; 2019; 18():1533033819892256. PubMed ID: 31829105
[TBL] [Abstract][Full Text] [Related]
45. Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1.
Xia L; Li F; Qiu J; Feng Z; Xu Z; Chen Z; Sun J
BMC Cancer; 2020 Oct; 20(1):949. PubMed ID: 33008330
[TBL] [Abstract][Full Text] [Related]
46. Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.
Yonemori M; Seki N; Yoshino H; Matsushita R; Miyamoto K; Nakagawa M; Enokida H
Cancer Sci; 2016 Sep; 107(9):1233-42. PubMed ID: 27355528
[TBL] [Abstract][Full Text] [Related]
47. miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL.
Wang Y; Chen L; Wu Z; Wang M; Jin F; Wang N; Hu X; Liu Z; Zhang CY; Zen K; Chen J; Liang H; Zhang Y; Chen X
BMC Cancer; 2016 Nov; 16(1):826. PubMed ID: 27842510
[TBL] [Abstract][Full Text] [Related]
48. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-598 acts as an inhibitor in retinoblastoma through targeting E2F1 and regulating AKT pathway.
Liu F; Zhang Q; Liang Y
J Cell Biochem; 2020 Mar; 121(3):2294-2302. PubMed ID: 31674056
[TBL] [Abstract][Full Text] [Related]
50. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
Li GH; Yu JH; Yang B; Gong FC; Zhang KW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
[TBL] [Abstract][Full Text] [Related]
51. MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1.
Bao C; Chen J; Chen D; Lu Y; Lou W; Ding B; Xu L; Fan W
Cell Death Dis; 2020 Aug; 11(8):618. PubMed ID: 32796817
[TBL] [Abstract][Full Text] [Related]
52. E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter.
Chu J; Zhu Y; Liu Y; Sun L; Lv X; Wu Y; Hu P; Su F; Gong C; Song E; Liu B; Liu Q
Oncotarget; 2015 Oct; 6(31):31944-57. PubMed ID: 26397135
[TBL] [Abstract][Full Text] [Related]
53. miR-542-3p targets sphingosine-1-phosphate receptor 1 and regulates cell proliferation and invasion of breast cancer cells.
Wu HX; Wang GM; Lu X; Zhang L
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):108-114. PubMed ID: 28121348
[TBL] [Abstract][Full Text] [Related]
54. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.
Kong Q; Qiu M
Biochem Biophys Res Commun; 2018 Jan; 495(2):1594-1600. PubMed ID: 29217194
[TBL] [Abstract][Full Text] [Related]
55. Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.
Xu X; Lv YG; Yan CY; Yi J; Ling R
Biochem Biophys Res Commun; 2016 Oct; 479(4):893-900. PubMed ID: 27693788
[TBL] [Abstract][Full Text] [Related]
56. Circular RNA-100219 promotes breast cancer progression by binding to microRNA-485-3p.
Yao Y; Fang ZZXHSLCNH
J BUON; 2019; 24(2):501-508. PubMed ID: 31127997
[TBL] [Abstract][Full Text] [Related]
57. ATF-3/miR-590/GOLPH3 signaling pathway regulates proliferation of breast cancer.
Song Q; Chen Q; Wang Q; Yang L; Lv D; Jin G; Liu J; Li B; Fei X
BMC Cancer; 2018 Mar; 18(1):255. PubMed ID: 29534690
[TBL] [Abstract][Full Text] [Related]
58. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.
Yao Y; Hu J; Shen Z; Yao R; Liu S; Li Y; Cong H; Wang X; Qiu W; Yue L
J Cell Mol Med; 2015 Apr; 19(4):760-9. PubMed ID: 25639535
[TBL] [Abstract][Full Text] [Related]
59. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B
J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817
[TBL] [Abstract][Full Text] [Related]
60. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
